TechNavio's analysts forecast the Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for high-speed diagnosis. The Biochips market in North America has also been witnessing the increasing outsourcing activities by drug manufacturers. However, the high cost incurred in the implementation of biochips could pose a challenge to the growth of this market.
TechNavio's report, the Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux S.A., BioRad Laboratories, Cepheid Inc., Danaher Corp., GE Healthcare Ltd., Microarrays Inc., Qiagen N.V, Promega Corp., Illumina Inc., Life Technologies Corp., Roche Holding AG, Perkin Elmer Inc., and Siemens Healthcare Diagnostics.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Category
07.1 Biochips Market in North America by Category
08. Market Segmentation by Product
08.1 Biochips Market in North America by Product
09. Market Segmentation by Application
09.1 Biochips Market in North America by Application
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Affymetrix Inc.
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 Agilent Technologies
18.2.1 Business Overview
18.2.2 Key Information
18.2.3 SWOT Analysis
18.3 Life Technologies Corp.
18.3.1 Business overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Illumina Inc.
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
18.5 Roche Holding AG
18.5.1 Business Overview
18.5.2 Business Segmentation
18.5.3 Key Information
18.5.4 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Classification of the Biochips market in North America
Exhibit 3: Biochips Market in North America 2013-2018 (US$ billion)
Exhibit 4: Biochips Market in North America Segmentation by Category
Exhibit 5: Biochips Market in North America Segmentation by Category 2013
Exhibit 6: Biochips Market in North America Segmentation by Product
Exhibit 7: Biochips Market in North America Segmentation by Product 2013
Exhibit 8: Biochips Market in North America Segmentation by Application
Exhibit 9: Business Segmentation of Affymetrix Inc.
Exhibit 10: Business Segmentation of Agilent Technologies Inc.
Exhibit 11: Business Segmentation of Life Technologies Corp.
Exhibit 12: Business Segmentation of Illumina Inc.
Exhibit 13: Business Segmentation of Roche Holding AG